Iohexol
- Generic Name
- Iohexol
- Brand Names
- Omnipaque, Oraltag
- Drug Type
- Small Molecule
- Chemical Formula
- C19H26I3N3O9
- CAS Number
- 66108-95-0
- Unique Ingredient Identifier
- 4419T9MX03
- Background
Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
- Indication
Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.
Virtual Colonoscopy Using Omnipaque as a Contrast Agent
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT04582500
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
- Conditions
- Breast CancerHER2-negative Breast CancerER Positive Breast CancerPR-Positive Breast Cancer
- Interventions
- Diagnostic Test: Computed tomography (CT)
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Jennifer Lee Caswell-Jin
- Target Recruit Count
- 4
- Registration Number
- NCT04504331
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
- Conditions
- Polycystic Kidney Disease, AdultPolycystic Kidney, Autosomal Dominant
- Interventions
- First Posted Date
- 2020-05-29
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 22
- Registration Number
- NCT04407481
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
- Conditions
- Abdominal CancerPelvic Cancer
- Interventions
- Radiation: Cone Beam CTRadiation: Radiation TherapyDrug: 0.9% Saline
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 6
- Registration Number
- NCT04199754
- Locations
- 🇺🇸
Columbia University Irving Medical Center/Department of Radiation Oncology, New York, New York, United States
A Study of LY3556050 in Healthy Participants
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 34
- Registration Number
- NCT04156750
- Locations
- 🇺🇸
Covance, Dallas, Texas, United States
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
- Conditions
- Heart Failure
- Interventions
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT04113109
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin Resistance
- Conditions
- Type 1 DiabetesDiabetesDiabetes MellitusType1diabetesDiabetes, AutoimmuneDiabetic Kidney DiseaseDiabetes ComplicationsDiabetic NephropathiesAutoimmune DiabetesJuvenile Diabetes
- Interventions
- Radiation: PET/CT ScanProcedure: Renal Biopsy
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 58
- Registration Number
- NCT04074668
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
- Conditions
- Malignant Solid Neoplasm
- Interventions
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 350
- Registration Number
- NCT03997370
- Locations
- 🇺🇸
University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
🇺🇸University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
🇺🇸Banner University Medical Center - Tucson, Tucson, Arizona, United States
Iohexol for Measuring Renal Function
- Conditions
- Acute Kidney InjuryCritically Ill Children
- First Posted Date
- 2019-05-10
- Last Posted Date
- 2019-05-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 105
- Registration Number
- NCT03946345
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Netherlands
Pilot Study DiaDEP
- Conditions
- Type1diabetesDiabetes Mellitus, Type 1
- Interventions
- Device: microcirculation assessment through Laser Doppler associated to iontophoresis.Device: Cardiovascular assessment though Intima-media Thickness and Extra-media Thickness measurementBiological: Blood samplingBiological: Urine samplingDevice: High-resolution peripheral quantitative computed tomography (HR-pQCT)Radiation: Dual-energy X-ray (DXA)
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 23
- Registration Number
- NCT03912012
- Locations
- 🇫🇷
Hopital Femme Mère Enfant - Groupement Hospitalier Est, Bron, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.